Cargando…

DOACs or VKAs or LMWH – What is the optimal regimen for cancer-associated venous thromboembolism? A systematic review and meta-analysis

BACKGROUND: Clinical guidelines have supported the use of direct anticoagulants (DOACs) for the treatment of cancer-associated venous thromboembolism (Ca-VTE). However, recent trials have reported increased bleeding risks associated with DOACs usage, raising concerns regarding its efficacy. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamani, Naser, Unzek, Samuel, Almas, Talal, Musheer, Adeena, Ejaz, Arooba, Paracha, Anousheh Awais, Shahid, Izza, Mookadam, Farouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Systematic Review / Meta-analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289311/ https://www.ncbi.nlm.nih.gov/pubmed/35860059 http://dx.doi.org/10.1016/j.amsu.2022.103925

Ejemplares similares

Efficacy of Sodium-Glucose Cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: An updated meta-analysis
por: Yamani, Naser, et al.
Publicado: (2021)

Does individualized guided selection of antiplatelet therapy improve outcomes after percutaneous coronary intervention? A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2022)

Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Diagnosis, treatment, and management of pericardial effusion- review
por: Yamani, Naser, et al.
Publicado: (2022)

Meta-analysis evaluating the impact of chili-pepper intake on all-cause and cardiovascular mortality: A systematic review
por: Yamani, Naser, et al.
Publicado: (2021)

Efficacy and safety of direct oral anticoagulants with and without Aspirin: A systematic review and Meta-analysis
por: Almas, Talal, et al.
Publicado: (2022)

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022)

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
por: van Gorp, Rick H., et al.
Publicado: (2015)

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Liu, Fuwei, et al.
Publicado: (2021)

Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta‐analysis
por: Yan, Jie, et al.
Publicado: (2022)

Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: A systematic review and meta-analysis
por: Almas, Talal, et al.
Publicado: (2022)

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
por: Noviyani, Rini, et al.
Publicado: (2022)

Multiple symptomatic giant coronary aneurysms
por: Vukomanovic, Damir, et al.
Publicado: (2022)

Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2021)

Strangulation: A Cause or Mimicker of Global Myocardial Hypoxia on ECG
por: Vukomanovic, Damir, et al.
Publicado: (2022)

CLRM-03 INCIDENCE OF INTRACRANIAL HEMORRHAGE IN GLIOMA PATIENTS WITH VENOUS THROMBOEMBOLISM CONVERTED FROM LMWH TO APIXABAN
por: Aboud, Orwa, et al.
Publicado: (2022)

COVID-19 and Diarrhoea: the Therapeutic Role OF LMWH
por: Dioscoridi, Lorenzo, et al.
Publicado: (2021)

Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Virulent endocarditis due to Haemophilus parainfluenzae: A systematic review of the literature
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
por: Leung, Timothy S, et al.
Publicado: (2015)

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
por: Ozaslan, Ersin, et al.
Publicado: (2018)

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
por: Mookadam, Martina, et al.
Publicado: (2015)

Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres
por: Motlekar, Nusrat, et al.
Publicado: (2009)

The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021)

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
por: Wei, Qingqing, et al.
Publicado: (2023)

DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines
por: Cominacini, Mattia, et al.
Publicado: (2022)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
por: Wang, Lu, et al.
Publicado: (2023)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Continuous administration of LMWH in critical patients: a contribution to the monitoring of hemocoagulation
por: Stach, Z, et al.
Publicado: (2006)

DOAC in COVID-19: Yes or No?
por: Schutgens, Roger E.
Publicado: (2020)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)
por: Farge, Dominique, et al.
Publicado: (2018)

A Coronary Conundrum: Papillary Muscle Rupture and Ischemic Mitral Regurgitation Secondary to Coronary Thromboembolism in Antiphospholipid Syndrome
por: Shere, Amar, et al.
Publicado: (2019)

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms
por: Huenerbein, Karlo, et al.
Publicado: (2020)

A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides
por: Miller, Gavin J., et al.
Publicado: (2015)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

SARS-COV-2 VACCINE INDUCED MYOCARDITIS WITH SEVERE QT PROLONGATION
por: Martinez, Jake Cordell, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dlf1mkajfsg71h18lv8o3l6rsi